Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06513091 · ClinicalTrials.gov registry record
US National TOP Registry
A clinical trial of Lung Transplant, sponsored by TransMedics.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 7
- Study locations
NCT06513091 is a study of Lung Transplant that is actively recruiting participants, run by TransMedics. The registered enrollment target is 10,000 participants, above the 609-participant average among 15 other Lung Transplant trials with a reported enrollment target (1542% higher). The trial reports 7 study locations across 6 states.
The verdict
NCT06513091, a study of Lung Transplant, is actively recruiting participants, sponsored by TransMedics.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 7
- Study locations
Study Summary
The objective of this Registry is to collect short and long-term post-transplant clinical outcome data of all donor lungs preserved and assessed on the OCS Lung System and to document the performance of the OCS device in the real-world setting after FDA approval in the US.
Conditions Studied
Interventions
- DEVICE OCS Lung
Study Locations (7)
Texas
- Baylor Scott & White Research Institute - Dallas
- Baylor College of Medicine - Houston
Arizona
- St. Joseph's Hospital & Medical Center - Phoenix
California
- Stanford University School of Medicine - Stanford
Minnesota
- University of Minnesota - Minneapolis
North Carolina
- Duke University - Durham
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2025-01-23 |
| Est. Completion | 2039-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06513091
The ClinicalTrials.gov registry entry for NCT06513091 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 609-participant average among 15 other Lung Transplant trials with a reported enrollment target (1542% higher). The listed sponsor is TransMedics, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Transplant appearing as the primary indexed condition, and to 1 intervention - of which OCS Lung is the first listed.
NCT06513091 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Texas, Arizona, California.
Frequently Asked Questions
What is clinical trial NCT06513091 about?
NCT06513091 is a clinical study titled "US National TOP Registry". The objective of this Registry is to collect short and long-term post-transplant clinical outcome data of all donor lungs preserved and assessed on the OCS Lung System and to document the performance of the OCS device in the real-world setting after FDA approval in the US.
What is the current status of trial NCT06513091?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2025-01-23. Estimated completion is 2039-11.
What conditions does trial NCT06513091 study?
This clinical trial studies the following conditions: Lung Transplant.
What interventions are being tested in trial NCT06513091?
The interventions under investigation include: OCS Lung (DEVICE).
Who is sponsoring clinical trial NCT06513091?
This trial is sponsored by TransMedics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06513091 being conducted?
This trial has 7 study locations across Arizona, California, Minnesota, North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies
RECRUITING
-
Pre-transplant Health Coaching to Improve Patient-Reported Outcomes in Lung Transplant Candidates
RECRUITING · NA
-
Planned Semi-Elective Lung Tx Study
RECRUITING · NA
-
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
RECRUITING · Phase 2
-
Tocilizumab in Lung Transplantation
RECRUITING · Phase 2
-
An All Comers Registry For Normothermic Ex Vivo Lung Perfusion (EVLP) as Assessment of Donor Lungs for Transplant
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.